Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Adults With Suspected Genetic Neurological Disorders

NCT04170985 is registered in ClinicalTrials.gov with Illumina, Inc. as lead sponsor.

NCT NCT04170985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04170985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Adults With Suspected Genetic Neurological Disorders
Lead sponsor
Illumina, Inc.
Phase
Observational
Overall status
Completed
Start date
November 18, 2019
Completion date
January 31, 2024
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurologic abnormalities, neurologic deficits, neurologic disorder